The Efficacy and Safety of Iguratimod (IGU) in the Treatment of Primary Sjögren's Syndrome

NCT04981145 · clinicaltrials.gov ↗

PHASE4

Phase

RECRUITING

Status

78

Enrollment

OTHER

Sponsor class

Conditions

Primary Sjögren's Syndrome

Interventions

DRUG: Iguratimod Tablets
DRUG: Hydroxychloroquine Sulfate Tablets

Sponsor

Second Affiliated Hospital, School of Medicine, Zhejiang University